Corporate Presentation June 2020 PI Industries Ltd www.piindustries.com VISIO ISION “Building on the foundation of trust, we shall be at the forefront of science- led opportunities by delivering innovative solutions.” VALUES TRUST SPEED INNOVATION ADAPTABILITY Like the earth, we are Blazing ahead, like fire, we Enlivening, like the air, in the Adaptive, like water, we are dependable. We work with constantly strive to work with constant quest for the constantly transforming integrity of purpose, honesty in speed in the way we observe, horizon, the never-ending ourselves. Being nimble action and fairness in all our think and act search for a better, newer footed, we are highly dealings way to do things; Innovation, responsive to change for us, is a way of life Corporate Presentation - June 2020 1
Our value proposition Strong tangibles: R&D, Favorable dynamics driving Offerings across the value Business model ready to manufacturing, extensive Quality governance, talent Performance over a long Indian chemical industry chain driven by strategic go beyond Ag-Chem network of & learning skills term period growth partnership intangibles: Brands 1 2 3 4 5 6 • Global specialty chemicals • Business built on end-to- • Integrated and innovative • Globally certified with use • Professionals with • Revenue CAGR (FY18- market expected to grow end partnerships with services to provide of Technology, 4 expertise across various FY20) of 21.6% 2 at 5.4% CAGR 1 global innovators • Comprehensive solutions manufacturing facilities, technical and business • EBITDA CAGR (FY18-FY20) 12 multi purpose plants functions • Increasing focus on CSM • ~90% CSM revenues from by partnerships of 20.6% 3 • 5 formulation facilities • Senior management team as innovators shift focus patented molecules; • Relationships with 20+ • Pre-tax RoCE of more than to core competencies, 60%+ domestic revenues of qualified experienced • R&D team of ~300 global innovators built on 20% over last 3 years 4 developing new active from in-licensed professionals IP protection researchers and scientists ingredients and outsource molecules • Technology enabled production • Proven capabilities in distribution network and • M&A activities boosting agrochemicals; now ready relationships with more specialized CSM players to be replicated across than 2.5 million • Emerging new areas of other chemicals segments farmers/retailers • FY21 started with entry innovation such as batteries, coatings, etc. into pharma value chain - • Global supply chain risk successfully developed and scaled up an diversification: China intermediate for a facing issues – pollution, promising Covid-19 drug trade wars, safety issues Well positioned to capture value from changing market landscape Note: (1) FY19-24 CAGR; Source: Frost & Sullivan; (2) Revenue = Revenue from operating - excise duty; (3) EBITDA = Revenue - Cost of Materials consumed - Purchase of Stock in Trade - Changes in Inventories of FG, WIP and stock in trade - Employee Benefits expense - Other Expenses; (4) Pre-tax RoCE % = (EBITDA – D&A) / Average Capital Employed (CE); CE = Net Debt + Total Equity. Corporate Presentation - June 2020 2
Over 70 years, built several businesses, partnerships 1961 Ag-Chem Formulation and Marketing 1971 Mining later hived off 1976 First Technical Manufacturing plant 1985 Energy Metering, later hived off 1992 Name Changed to PI Industries Limited 1993 Facility at Panoli (Gujarat) 1993 PILL Finance and Investment Ltd. 1995 Polymer Compounding later divested 1996 Custom Synthesis & Manufacturing 2011 GLP Certification 1st company in the Ag-chem to 2011 Inauguration of PI-Sony Research Centre 2001 implement SAP 2014 Germany office Formulation site setup at Panoli 2015 (Gujarat) Founded as The Mewar 1946 PI Life Science Research Ltd. 2004 Oil and General Mills Ltd. Joint Venture – Solinnos 2016 Established Subsidiary in Japan New R&D Centre at Udaipur 2007 (PI Japan Co. Ltd) 2017 Joint Venture – PI Kumiai Pvt. Ltd. Started New Rep Office in 2008 China (Shanghai) 2019 M&A – acquired Isagro Asia Continuingly creating value propositions for the stakeholders … Corporate Presentation - June 2020 3
Present across the global Ag-chem value chain with a partnership approach Global Export Business - CSM Domestic Business – Brands Regulatory Marketing & Discovery Development Scale-up Manufacturing Evaluation & Trials services & Distribution Registrations • Product Pre and • Process Development • Large Scale • Geography Specific • CIB Intimation / • Library Synthesis • Analytical • Molecule Design Post Launch Manufacturing Bio-Efficacy RTT application / • Offering multiple • Lead Optimization Activities & Development Studies Sample import • Kilo Lab Studies • Evaluation & Trials • Inclusion in the • Route Synthesis Campaign chemical reaction • Product • Pilot Plant Trials • Biological testing (High pressure to Data Compilation Schedule • Basic Engineering • Geographical • Dossier • Green house Stewardship low temperature) • Crop Diversification • Process Optimization • Formulations testing Potential / Fitment Preparation & • Combination • Detailed Engineering • Micro Field Evaluation Submission • Plan Design • Bio - efficacy Development • HAZOP Studies • Small Scale • Residue Studies • Toxicity Studies manufacturing for • Packaging trails • Formulation Specifications Development Development Leverage our capabilities by providing integrated and innovative services & solutions with respect for IP and relationships Corporate Presentation - June 2020 4
Business model built on the principles of respect for IP and established relationships Leading Ag-chem India’s largest CRAMS Company Distribution Company in with over 90% Revenue from Domestic Brand Market Exports Market India with leading market Patented Products share in certain crops Leveraging our Pan India network, Leveraging on chemistry process research demonstrating brand building capabilities and manufacturing capabilities catering to and experienced team to deliver in- R&D Global Innovators; Partnering for IP licensed, branded generics & co-marketed Partnership Creation. products SYNERGISTIC APPROACH IN-LICENSING Custom Synthesis & Manufacturing • Introducing new products, partnering with • Early stages of their life cycles Common Infrastructure global innovators • Complex Chemistries Develop knowledge, products, • Ensure longer product cycles by brand building • Process development processes and experience in • Develop solutions for the Indian Ag-chem • IP Protection & Generation different complex chemistries Industry with the partnership approach Cross-Selling Opportunities • To service its customers • • 3 Global locations State of the Art R&D facilities • 1 R&D Facility • ― Japan for business ~300 researchers and • 4 Manufacturing Sites development activities scientists Consistent track record of • Domestic Brand Distribution financial performance • China for Sourcing ― Accredited for GLP and ― 28 stock points ‘Norms on OECD • Germany for Knowledge ― 10,000+ distributors Principles’ by NGCMA Management ― 70,000 retail points Non conflicting business model … well respected by Global Innovators as Partners !!! Corporate Presentation - June 2020 5
Recommend
More recommend
